V. D. Velden

Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease

J. Dongen, T. Szczepański, J. V. Dongen, 2003, Leukemia.

Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease – a study within the Europe Against Cancer Program

T. Lion, J. Dongen, N. Boeckx, 2004, Leukemia.

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

J. Dongen, G. Schuurhuis, K. Wheatley, 2010, Leukemia.

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg®) treatment in acute myeloid leukemia patients

J. Dongen, M. Boogaerts, N. Boeckx, 2004, Leukemia.

The Validity of Sentiment Analysis: Comparing Manual Annotation, Crowd-Coding, Dictionary Approaches

V. D. Velden, van Atteveldt, 2021 .